Palliative therapy in cancer patients: An overview

JK Science

Volumn 7, Issue 2, 2005, Pages 67-72

  Suhag, Virender ^a,b  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

^b NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPRAZOLAM; AMITRIPTYLINE; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIEMETIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; ANTITUSSIVE AGENT; ANXIOLYTIC AGENT; APPETITE STIMULANT; BISACODYL; BISMUTH SALICYLATE; BISPHOSPHONIC ACID DERIVATIVE; BLEOMYCIN; BRONCHODILATING AGENT; BUPIVACAINE; CHLORPROMAZINE; CISPLATIN; CLODRONIC ACID; CLOVE OIL; DIAZEPAM; DIGOXIN; DIPHENOXYLATE; DIURETIC AGENT; DOMPERIDONE; ENEMA; FLUCONAZOLE; FLUOROURACIL; FLUOXETINE; FUROSEMIDE; GASTROINTESTINAL AGENT; GLYCEROL; HISTAMINE H2 RECEPTOR ANTAGONIST; IMIPRAMINE; INDOMETACIN; INTERLEUKIN 2; IRINOTECAN; KETOCONAZOLE; LACTULOSE; LAXATIVE; LOPERAMIDE; LORAZEPAM; MENTHOL; METHOTREXATE; METOCLOPRAMIDE; MORPHINE; MUCOLYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NYSTATIN; OCTREOTIDE; ONDANSETRON; OPIATE; PAMIDRONIC ACID; PEPPERMINT OIL; PHENOL; PHENYTOIN; PHOSPHATE; SALICYLIC ACID; SENNA EXTRACT; SEROTONIN 3 ANTAGONIST; SIMETHICONE; SODIUM CHLORIDE; SORBITOL; SPIRONOLACTONE; STEROID; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VINCA ALKALOID;

ADVANCED CANCER; ANOREXIA; ASCITES; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CONSTIPATION; COUGHING; DIARRHEA; DYSPNEA; GASTROINTESTINAL SYMPTOM; HALITOSIS; HICCUP; HOME CARE; HUMAN; LYMPHEDEMA; MEDICOLEGAL ASPECT; MENTAL DISEASE; MENTHA SPICATA; METALLIC TASTE; MOUTH HYGIENE; MOUTHWASH; NAUSEA; PROGNOSIS; REVIEW; SYMPTOMATOLOGY; TASTE DISORDER; TERMINAL DISEASE; THRUSH; VOMITING; XEROSTOMIA;

EID: 20544462799     PISSN: 09721177     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. D'Silva JV. Palliative care: a challenge for nurses. Nurs J India 2000; 91(2): 31.
2. Pat SK, Mittal B. Improving cancer care in India: prospects and challenges. Asian Pac J Cancer Prev 2004; 5(2): 226-28.
3. Nayak S. The concept of hospice in theory and practice. J Ind Med Assoc 2001; 99(12): 687-88.
4. Abrahm JL. Update in palliative medicine and end-of-life care. Annu Rev Med 2003;54: 53-72.
5. Yuen KJ, Behrndt MM, Jacklyn C, Mitchell GK. Palliative care at home: general practitioners working with palliative care teams. Med J Aust 2003; 179 (6): S38-40.
6. Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 2000; 8(3): 175-79.
7. Morita T, Tsunoda J, Inoue S, Chihara S. Contributing factors to physical symptoms in terminally-ill cancer patients. J Pain Symptom Manage 1999; 18(5): 338-46.
8. Portenoy RK, Lesage P. Management of cancer pain. Lancet 1999; 353(9165): 1695-1700.
9. Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain 1995; 63(1): 65-76.
10. Farrar JT, Portenoy RK. Neuropathic cancer pain: the role of adjuvant analgesics. Oncology (Huntingt) 2001; 15(11): 1035-45.
11. Hwang SS, Chang VT, Kasimis B. Dynamic cancer pain management outcomes: the relationship between pain severity, pain relief, functional interference, satisfaction and global quality of life over time. J Pain Symptom Manage 2002; 23(3): 190-200.
12. Cullinane CA, Chu DZ, Mamelak AN. Current surgical options in the control of cancer pain. Cancer Pract 2002; 10(1): S21-6.
13. Levy MJ, Wiersema MJ. EUS-guided celiac plexus neurolysis and celiac plexus block. Gastrointest Endosc 2003; 57(7):923-30.
14. Takiguchi Y, Watanabe R, Nagao K, Kuriyama T. Hiccups as an adverse reaction to cancer chemotherapy. J Natl Cancer Inst 2002; 94(10): 772-73.
15. Dev SV, Ray S, Rath GK, Shukla NK, Kar M, Asthana S etal. Prevalence and risk factors for development of lymphedema following breast cancer treatment. Ind J Cancer 2004; 41(1): 8-12.
16. Kligman L, Wong RK, Johnston M, Laetsch NS. The treatment of lymphedema related to breast cancer: a systematic review and evidence summary. Support Care Cancer 2004; 12(6): 421-31.
17. Bruns F, Buntzel J, Mucke R, Schonekaes K, Kisters K, Micke O. Selenium in the treatment of head and neck lymphedema. Med Princ Pract 2004; 13(4): 185-90.
18. Komurcu S, Nelson KA, Walsh D, Ford RB, Rybicki LA. Gastrointestinal symptoms among inpatients with advanced Cancer. Am J Hosp Palliat Care 2002; 19(5): 351-5.
19. Ballatori E, Roila F. Impact of Nausea and Vomiting on Quality of Life in Cancer Patients During Chemotherapy. Health Qual Life Outcomes 2003; 1(1): 46.
20. Buijt I, Wait S, Groot AU. Economics and health-related quality of life in antiemetic therapy: recommendations for trial design. Euro J Cancer 2000; 36(12): 1522-35.
21. Hesketh PJ. Comparative review of 5-HT, receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting. Cancer Invest 2000; 18: 163-73.
22. Gralla RJ, Osoba D, Kris MG. Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines: American Society of Clinical Oncology. J Clin Oncol 1999; 17: 2971-94.
23. Weitzman S. Alternative nutritional cancer therapies. Int J Cancer 1998; 11: 69-72.
24. John Barstis. Gastrointestinal Problems: Diarrhoea. In: Haskell CM (ed). Cancer treatment. Philadelphia: W.B.Saunders Company, 2001.pp. 334-37.
25. Schultz M, Scholmerich J, Kullmann F. Management of chemotherapy induced diarrhea. Z Gastro 2004; 42(6): 527-38.
26. Tsuji Y, Sagawa T, Takayanagi N, Hirayama Y, Sakamaki S. Management of cancer treatment-related diarrhea and constipation. Nippon Rinsho 2003; 61(6): 966-72.
27. Smith EM, Jayson GC. The current and future management of malignant ascites. Clin Oncol (R Coll Radiol) 2003; 15(2):59-72.
28. Oh EG. Symptom experience in Korean adults with lung cancer. J Pain Symptom Manage 2004; 28(2):133-39.
29. Wong S, Rosenthal MA, DeBoer R, Green MD, Fox RM. Five years managing metastatic non-small cell lung cancer: experience at a teaching hospital. Intern Med J 2004; 34(8): 458-63.
30. Vissink A, Burlage FR, Spijkervet FK, Jansma J, Coppes RP. Prevention and treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Biol Med 2003; 14(3):213-25.
31. Wickham RS, Rehwaldt M, Kefer C, Shott S, Abbas K, Glynn-Tucker E etal. Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum 1999; 26(4): 697-706.
32. Kugaya A, Akechi T, Okuyama T, Nakano T, Mikami I, Okamura H etal. Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer 2000; 89(12): 2817-23.
33. Rossi Ferrario S, Zotti AM, Massara G, Nuvolone G. A comparative assessment of psychological and psychosocial characteristics of cancer patients and their caregivers. Psychooncology 2003; 12(1): 1-7.
34. Ashby M. The role of radiotherapy in palliative care. J Pain Symptom Manage 1991; 6(6): 380-88.
35. Barclay S, Todd C, Grande G, Lipscombe J. How common is medical training in palliative care? A postal survey of general practitioners. Br J Gen Pract 1997; 47(425): 800-04.
36. Ghooi RB, Ghooi SR. Freedom from pain-a mirage or a possibility? Experience in attempts to change laws and practices in India. J Pain Palliat Care Pharmacother 2003; 17(3-4): 1-12.